Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03395262 · ClinicalTrials.gov registry record · NA
An Examination of a Weight Loss Formula on Health
A NA study, sponsored by Texas A&M University.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT03395262 is a NA study that has completed, run by Texas A&M University. The registered enrollment target is 80 participants.
The verdict
NCT03395262, a NA study, has completed, sponsored by Texas A&M University.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The aim of this study is to examine a novel weight loss formula with and without common stimulants on anthropometry and indices of cardiovascular disease risk.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Active with caffeine
- DIETARY_SUPPLEMENT Active without caffeine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2017-06-01 |
| Est. Completion | 2018-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03395262
The ClinicalTrials.gov registry entry for NCT03395262 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas A&M University, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT03395262 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03395262 about?
NCT03395262 is a clinical study titled "An Examination of a Weight Loss Formula on Health". The aim of this study is to examine a novel weight loss formula with and without common stimulants on anthropometry and indices of cardiovascular disease risk.
What is the current status of trial NCT03395262?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2017-06-01. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT03395262?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Active with caffeine (DIETARY_SUPPLEMENT), Active without caffeine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03395262?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.